tirzepatide injections atlanta is a New Medication for Diabetes and Weight Loss Tirzepatide Weight Loss Program |

Given promise as well as challenges, more research is needed on telehealth and digital interventions for adherence to GLP1 therapy, longterm weight management, and individual behaviors, health outcomes, quality of life, and satisfaction

The maximum weight loss is usually seen at 9 to 12 months of treatment

Tadworth: Electronic Medicines Compendium

GLP-1s, a class of drugs that include semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro and Zepbound), were initially prescribed to treat Type 2 diabetes, but have soared in popularity because of weight loss

While its clinical performance suggests that dual incretin agonism may redefine treatment expectations, careful integration into clinical practice will require continued evaluation of long term outcomes, comparative effectiveness, and health system implications

Analysts expect supply constraints to improve but note that the broader issue will take years to resolve